https://www.selleckchem.com/pr....oducts/bobcat339.htm
Tumor-absorbed doses ranged from 35 to 859cGy. Intra- and interpatient variations were observed. Mean decreases in PET parameters from baseline to 3months were ΔSUV 61%, ΔMTV 80%, and ΔTLG 77%. There was no overall correlation between tumor-absorbed dose and change in FDG PET or ceCT parameters at the lesion level or significant difference in tumor-absorbed doses between metabolic responders and non-responders after treatment. Our analysis does not show any correlation between tumor-absorbed doses and changes in FDG PET or ceCT parame
Curtir
Comentario
Compartilhar
